(Q53546193)

English

Effect of 12-week dulaglutide therapy in Japanese patients with biopsy-proven non-alcoholic fatty liver disease and type 2 diabetes mellitus.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

Effect of 12-week dulaglutide therapy in Japanese patients with biopsy-proven non-alcoholic fatty liver disease and type 2 diabetes mellitus. (English)

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

0 references

type 2 diabetes

0 references

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

author name string

Yuya Seko

1

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

Yoshio Sumida

2

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

Saiyu Tanaka

3

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

Kojiroh Mori

4

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

Hiroyoshi Taketani

5

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

Hiroshi Ishiba

6

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

Tasuku Hara

7

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

Akira Okajima

8

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

Atsushi Umemura

9

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

Taichiro Nishikawa

10

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

Kanji Yamaguchi

11

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

Michihisa Moriguchi

12

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

Kazuyuki Kanemasa

13

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

Kohichiroh Yasui

14

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

Shunsuke Imai

15

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

Keiji Shimada

16

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

Yoshito Itoh

17

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

publication date

5 December 2016

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

Hepatology Research

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

47

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

11

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

1206-1211

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

Causes of death in Japanese diabetics: A questionnaire survey of 18,385 diabetics over a 10-year period

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12837

21 January 2018

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12837

21 January 2018

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12837

21 January 2018

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12837

21 January 2018

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12837

21 January 2018

Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12837

21 January 2018

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12837

21 January 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12837

21 January 2018

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12837

21 January 2018

Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12837

21 January 2018

Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12837

21 January 2018

Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12837

21 January 2018

Identifiers

10.1111/HEPR.12837

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/27917557

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53546193&oldid=1531272448"